TREATMENTS OF DISORDERS OF MYELIN

Title:

TREATMENTS OF DISORDERS OF MYELIN

Document Type and Number:

WIPO Patent Application WO/2023/212521

Kind Code:

A3

Abstract:

The present disclosure relates to RNA molecules, recombinant nucleic acids, and gene therapy vectors for use in the treatment of diseases and disorders associated with a deficiency or dysfunction of myelin.

Inventors:

LAYER RICHARD (US)
PYKETT MARK (US)
ALLEN JEFFREY (US)

Application Number:

PCT/US2023/066117

Publication Date:

December 07, 2023

Filing Date:

April 24, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MYRTELLE INC (US)

International Classes:

A61K48/00; C12N15/86; A61P25/00

Domestic Patent References:

WO2022061378A2

2022-03-24

Foreign References:

US20170096683A1

2017-04-06

Attorney, Agent or Firm:

HAO, Jianming et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE PROTECTIVE AGAINST LYME DISEASE

Next Patent: SYSTEMS AND TECHNIQUES FOR SCHEDULING FEEDBACK-LESS HYBRID AUTOMATIC REPEAT RESOURCE REQUEST